Tonifies the blood

"Tonifies the blood" (or "Bu Xue") is a fundamental therapeutic principle in Traditional Chinese Medicine (TCM) rather than a discrete molecular target like a receptor or enzyme. It describes a pharmacological action aimed at treating "blood deficiency," a condition characterized by clinical symptoms such as pallor, dizziness, palpitations, and fatigue. Agents categorized under this action, such as Angelica sinensis, work by modulating the hematopoietic system, often stimulating the production of erythropoietin and promoting the proliferation of bone marrow cells (Zhu et al., 2017, Journal of Ethnopharmacology). In modern pharmacological terms, this process involves the regulation of various signaling pathways, including the JAK2/STAT5 pathway, and the maintenance of iron homeostasis (Wang et al., 2016, Scientific Reports). Because the term refers to a broad physiological effect achieved through multiple molecular interactions across several systems, it is not considered a single therapeutic target in conventional drug discovery. Instead, it represents a clinical outcome involving the synergy of multiple bioactive compounds on diverse biological processes like erythropoiesis and immune modulation (National Institute of Health/NCCIH).

Other names

Blood tonificationBu XueNourishing the bloodHematopoietic promotionSupplementing the blood

Promotion of hematopoietic stem cell (HSC) proliferation and differentiation, stimulation of erythropoietin (EPO) expression, and enhancement of iron absorption and utilization to increase hemoglobin and red blood cell counts.